Abstract:Abstract The records of 74 children who received cadaver renal transplants and cyclosporine (CsA) immunosuppression from August 1984 to August 1989 were reviewed and data analyzed on: 1) prednisone dosage; 2) CsA dosage; 3) 12‐hour serum trough CsA levels; 4) serum creatinine levels; 5) total serum cholesterol levels; 6) linear growth: 7) weight gain. The 74 patients were grouped according to age: Group 1: 0‐12 years old (N = 30); Group 2: 13‐15 yr old (N = 20); Group 3: 16 yr old and above (N = 24). For comparison, similar data were evaluated in 15 children on azathioprine and prednisone who maintained cadaver graft function for at least 3 yr. The use of CsA was associated with significantly improved graft survival in recipients of both first and retransplants; results were best in patients receiving CsA in the context of sequential therapy, with primary transplant recipients having actuarial graft survivals of 94 ± 3% and 91 ± 4% at 1 and 2 yr, respectively, and recipients of retransplants having 1 and 2 yr actuarial graft survivals of 82 ± 8% and 70 ± 10%. In each of the 3 groups of CsA recipients, there was a slow rise in serum creatinine levels over the 2 yr post‐transplant of 0.4–0.6 mg/dl, but this trend was not significant; a similar trend was seen in the comparison patients receiving azathioprine and prednisone. At 3 and 6 months post‐transplant, the CsA dosages used in Group 1 patients were significantly higher than those in Group 2 or 3, but by 2 yr there was no difference between groups. Trough serum CsA levels declined in a stepwise fashion over time, with significant late deviations, because of late rejection in the older age groups. In the 1st post‐transplant yr, prednisone dosages in the CsA‐treated patients under the age of 12 were significantly lower than in similarly aged patients receiving only azathioprine as maintenance immunosuppression. For each age range, the mean serum cholesterol values were generally at or greater than the 90th percentile values for a normal pediatric population. Sixty percent of Group 1 patients followed for at least 1 yr showed some improvement in their standard deviation scores (SDS) for height; moreover, growth in children less than 12 yr of age on CsA was dramatically better than that observed in recipients of similar age on azathioprine, as assessed by changes at 1 and 2 yr in their height SDS. SDS for weight improved uniformly in all age groups. Although the outlook for pediatric cadaver renal allograft recipients is generally bright, truly optimal rehabilitation will be achieved only when the problems of progressive renal dysfunction, hypercholesterolemia, suboptimal growth and weight gain out of proportion to height gain are successfully addressed.

Renal transplantation in Nordic children during two decades. A retrospective study †

Pediatric renal transplantation: clinical analysis of 23 cases]

Renal transplantation from HLA‐haploidentical living related donors: The Scandinavian multicenter study of the effects of cyclosporine immunosuppression

Renal transplantation in pediatric patients with special reference to long‐term cyclosporin treatment in childhood

Immunosuppressive Therapy in Pediatric Cadaveric Renal Transplantation

Clinical Study on Renal Transplantation in Aged Recipients:A Report of 126 Cases

Cadaver renal transplantation in children: Results with long‐term cyclosporine immunosuppresion

Good long-term renal graft survival and low incidence of cardiac pathology in adults after short dialysis period and renal transplantation in early childhood - a cohort study

Long‐term outcome of pediatric renal transplantation with donors younger than 6 years

Clinical Analysis of 2520 Renal Transplantations in One Center

Overview of pediatric renal transplantation

Outcome of Single Kidney Transplant from Pediatric Donors Younger Than 5 Years of Age after Cardiac Death in China: A Single Center Experience

Clinical Research on Pediatric Renal Transplantation

Kidney Transplantation from Small Pediatric Donors May Be Feasible to Those Who Developed Chronic Refractory Dialysis Hypotension: a Single-Center Experience.

Favorable Outcome After Single-kidney Transplantation From Small Donors in Children: A Match-controlled CERTAIN Registry Study

Clinical Research and Social Status Investigation for Donor and Recipient of Living-Related Kidney Transplant

Adult outcomes of childhood kidney replacement therapy in Europe from 2008 to 2019: an ERA Registry study

Characteristics and survival of young adults who started renal replacement therapy during childhood

Clinical study of effect on renal transplantation from donation of pediatric donors

Analysis of Factors Related to the Success of Pediatric Kidney Transplantation: A 35 Years Experience

A retrospective analysis of 40 cases of pediatric renal transplantation